Science Corporation is a clinical-stage medical technology company founded in 2021 by Max Hodak, former president of Neuralink. Headquartered in Alameda, California, it develops brain-computer interfaces and neural engineering technologies to restore vision, cognition, and mobility, including the PRIMA BCI retinal implant for patients with macular degeneration. The company has raised $490 million total, including a $230 million Series C in 2026, and operates Science Foundry to provide components and infrastructure for the field.